title: No gains in efficacy observed by adding gemcitabine to adjuvant therapy for lymph node-positive breast cancer.
authors.forename: Mary Kay
authors.initials: MK
authors.lastname: Barton
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D018719:Erb-b2 Receptor Tyrosine Kinases; D000093542:Gemcitabine; C508053:ERBB2 protein, human